Substituted benzimidazoles and quinazolines as antihypertensives

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

514318, 514322, 514333, 514338, 514383, 514394, 544370, 546194, 546199, 546271, 5483101, 548250, 548254, A61K 31415, C07D23506

Patent

active

054515831

ABSTRACT:
There are disclosed compounds of the formula ##STR1## wherein R.sup.1 and R.sup.2 are defined in the specification; n is 1 to 3;

REFERENCES:
patent: 4808715 (1989-02-01), Boyle et al.
patent: 4880804 (1989-11-01), Carini
patent: 5039814 (1991-08-01), Shuman
patent: 5187168 (1993-02-01), Primeau
patent: 5210092 (1993-05-01), Oku et al.
patent: 5215994 (1993-06-01), Oku et al.
patent: 5234936 (1993-08-01), Primeau
patent: 5283242 (1994-02-01), Ellingboe
Chem. Abst. 115:232250c (1991).
Chem. Abst. 115: 159142n (1991).
Chem. Abst. 115:71602b (1991).
Chem. Abst. 114:228914j (1991).
Chem. Abst. 114:164233b (1991).
Chiu, A., Euro Jour. Pharma: 157, 13-21 (1988).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Substituted benzimidazoles and quinazolines as antihypertensives does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Substituted benzimidazoles and quinazolines as antihypertensives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted benzimidazoles and quinazolines as antihypertensives will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1828284

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.